Accera's Alzheimer's trial fails, in yet another setback for disease

(Reuters) - Nestle SA-backed Accera Inc said on Tuesday its experimental Alzheimer's drug failed a late-stage study, adding to the laundry list of disappointments in the pursuit of an effective treatment for the rampant mind-wasting disease.

India issues fresh antibiotic guidelines to tackle superbug menace

MUMBAI (Thomson Reuters Foundation) - India, one of the world's biggest consumers of antibiotics, has issued new national guidelines on their use as part of a drive to fight the rise of drug-resistant superbugs.

Merck KGaA, Pfizer get priority review for bladder cancer drug

FRANKFURT (Reuters) - German drugmaker Merck KGaA and U.S. partner Pfizer have been granted priority review status in the United States as they seek to widen the use of immunotherapy drug avelumab to include bladder cancer.